APA (7th ed.) Citation

Laskin, J., Liu, S., Tolba, K., Heining, C., Schlenk, R., Cheema, P., . . . Duruisseaux, M. (2020). NRG1 fusion-driven tumors: Biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. Annals of Oncology, 31(12), 1693. https://doi.org/10.1016/j.annonc.2020.08.2335

Chicago Style (17th ed.) Citation

Laskin, J., et al. "NRG1 Fusion-driven Tumors: Biology, Detection, and the Therapeutic Role of Afatinib and Other ErbB-targeting Agents." Annals of Oncology 31, no. 12 (2020): 1693. https://doi.org/10.1016/j.annonc.2020.08.2335.

MLA (9th ed.) Citation

Laskin, J., et al. "NRG1 Fusion-driven Tumors: Biology, Detection, and the Therapeutic Role of Afatinib and Other ErbB-targeting Agents." Annals of Oncology, vol. 31, no. 12, 2020, p. 1693, https://doi.org/10.1016/j.annonc.2020.08.2335.